Retina-focused industry update exploring company initiatives and recent data releases that may influence future approaches to patient care.
Key Takeaways
- Early detection of wet age-related macular degeneration is critical because symptoms can progress rapidly
- EyePoint is promoting clinical trials to evaluate new retina treatments and generate supporting data
- Advancing retina care requires industry collaboration combined with early detection to improve patient outcomes